Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Patent
1990-08-21
1993-02-02
Millin, V.
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
128898, A61M 3100
Patent
active
051834626
ABSTRACT:
This invention relates to a method for controlled administration of chemodernervating agents such as botulinum toxin-derived pharmaceutical, useful in attenuating neural stimulation and spasmotic activity of muscle. The method involves administration of novel dosage forms based upon the standardization of denervating pharmaceuticals. The invention also relates to novel methods of administering chemodernervating agents in a controlled and reproducible manner so as to confine their effects to a given region of muscle mass while minimizing paresis in adjacent muscle tissue.
REFERENCES:
patent: 2979055 (1961-04-01), Beer et al.
patent: 3898983 (1975-08-01), Elam
patent: 4331145 (1982-05-01), Winter
patent: 4445515 (1984-05-01), Diresta
patent: 4501582 (1985-02-01), Schulz
patent: 4522302 (1985-06-01), Paikoff
patent: 4810243 (1989-03-01), Howson
patent: 4880014 (1989-11-01), Zarowitz et al.
patent: 4932936 (1990-06-01), Dykstra et al.
patent: 5053005 (1991-10-01), Borodic
patent: 5097834 (1992-03-01), Skrabal
Duchen, J. Neurol. Neurosurg. Psychiat., (1970) vol. 33 pp. 40-54.
Duchen et al. Physiological Society (1969), pp. 17p-18p.
Das et al.; BJCP (1989) 43:401-403 Botulinum toxin in treating spasticity.
Das et al.; Post. Med. Jour. (1989) 65:208-210 Effect of treatment with botulinum toxin on spasticity.
Annals of Neurology; (1990) 28:512-515. Treatment of Spasticity with Botulinum toxin; A Double Blind Study.
Dunkley et al.; JAP (1986) 372:115-129. Brain Research.
Current Bibliographies in Medicine--Clinical Use of Botulinum Toxic, DHH5 NIH No. 90-10, Sep. 1990.
Borodic, Botulinum A Toxin for the Treatment of Spasmodic Torticollis: Dysphagia and Regional Toxin Spread, Head & Neck, Sep./Oct. 1990, pp. 392-399.
Gelb et al., Controlled Trial of Botulinum Toxin Injections in the Treatment of Spasmodic Torticollis, Neurology 1989, 39, pp. 80-84.
Tsui et al., A Pilot Study on the Use of Botulinum Toxic in Spasmodic Torticollis, Canadian J. Neurological Science, pp. 314-316, vol. 12, No. 4 Nov. 1985.
Tsui et al., Local Treatment of Spasmodic Torticollis with Botulinum Toxin, Canadian J. of Neurological Sci, vol. 14, No. 3 (Supplement), pp. 533-535 Aug. 1987.
Ludlow et al., Spasmodic Dysphonia: Botulinum Toxin Injection After Recurrent Nerve Surgery, Otolaryingol Head Neck Surg., pp. 122-131, vol. 102, No. 2, Feb. 1990.
Blitzer et al., Botulinum Toxin Injection for the Treatment of Oromandibular Dystonia, Ann Otol Rhinol Laryngol, pp. 93-97, vol. 98, 1989.
Jankovic et al., Botulinum A Toxin for Cranial-Cervical Dystonia: A Double-Blind, Placebo-Controlled Study, Neurology, pp. 616-623, vol. 37, Apr. 1987.
Borodic et al., Innervation Zone of Orbicularis Oculi Muscle and Implications for Botulinum A Toxin Therapy, Ophthalmic Plastic and Reconstructive Surgery, pp. 54-60, vol. 7(1), 1991.
Borodic et al., Blepharospasm and Its Treatment, with Emphasis on the Use of Botulinum Toxin, Plastic and Reconstructive Surgery, pp. 546-554, vol. 83, No. 3, Mar. 1989.
Zandijcke et al., Treatment of Bruxism with Botulinum Toxin Injections, Journal Neurol., Neurosurg., Psychiatry, vol. 53, pp. 530, 1990.
Associated Synapse Biologics
Millin V.
Passaniti Sebastiano
LandOfFree
Controlled administration of chemodenervating pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled administration of chemodenervating pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled administration of chemodenervating pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4984